CalciMedica, Inc. (CALC) News
Track canonical SquawkNews coverage tagged to CALC, CalciMedica, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 18 indexed stories across 7 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
CalciMedica to participate in H.C. Wainwright global investment conference
CalciMedica, Inc. said it will participate in the H.C. Wainwright 28th Annual Global Investment Conference.
EQUITY | Sep 08, 2026, 11:08 AM UTC
L
CALC - CalciMedica to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
CALC - CalciMedica to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
EQUITY | Sep 08, 2026, 11:00 AM UTC
L
CalciMedica says Nasdaq closed MVLS non-compliance
CalciMedica said Nasdaq closed its MVLS non-compliance after it met alternative stockholders’ equity criteria, while its minimum $1 bid-price issue remains unresolved.
REGULATION | Sep 02, 2026, 12:44 PM UTC
L
CalciMedica plans share split for Nasdaq minimum bid compliance
CalciMedica intends a share split aimed at meeting Nasdaq Capital Market minimum bid price requirements for continued listing.
EQUITY | Aug 27, 2026, 01:01 PM UTC
L
CalciMedica announces one-for-five reverse stock split
CalciMedica (CALC) announced a one-for-five reverse stock split.
EQUITY | Aug 27, 2026, 01:00 PM UTC
L
Guggenheim initiates CALC at Buy with $9.00 target
Guggenheim initiates CALC at Buy with a $9.00 price target; no catalyst was supplied in the alert.
EQUITY | Aug 20, 2026, 11:56 AM UTC
L
Guggenheim initiates Buy on CALC with $9.00 target
Guggenheim initiates CALC at Buy with a $9.00 price target, according to the raw alert; no catalyst was supplied.
EQUITY | Aug 20, 2026, 11:56 AM UTC
L
Guggenheim starts CALC at Buy, sets $9 target
Guggenheim initiates coverage of CALC with a Buy rating and a $9 price target.
EQUITY | Aug 20, 2026, 11:43 AM UTC
L
CALC Calcimedica announces FDA alignment on phase 2B trial Design for auxora in acute pancreatitis and identifies disease's first potential
CALC Calcimedica announces FDA alignment on phase 2B trial Design for auxora in acute pancreatitis and identifies disease's first potential registrational endpoints Calcimedica - FDA aligns on phase 2B primary endpoint o
REGULATION | Jul 29, 2026, 11:00 AM UTC
M
12 Health Care Stocks Move
Gainers Universe Pharmaceuticals (NASDAQ: UPC ) stock moved upwards by 168.2% to $7.94 during Friday's after-market session. The market value of their outstanding shares is at $1.8 million. Tvardi Therapeutics (NASDAQ: T
EQUITY | Jun 26, 2026, 11:20 PM UTC
H
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers INVO Fertility (NASDAQ: IVF ) shares moved upwards by 67.3% to $2.08 during Friday's regular session. The market value of their outstanding shares is at $2.2 million. The company's, Q1 earnings came out 4 days ag
EARNINGS | Jun 26, 2026, 05:05 PM UTC
M
12 Health Care Stocks Move
Twelve health care stocks are moving in Wednesday's intraday session, with Pulsenmore and Icecure Medical leading the gainers and Aditxt and Atlantic International among the losers
EQUITY | Jun 24, 2026, 05:05 PM UTC
M
CALC Advances Trial
CalciMedica advances trial after FDA raises no concerns over Auxora safety data
EQUITY | Jun 24, 2026, 12:36 PM UTC
M
CALC: Announces $49M Placement
CalciMedica announces private placement worth up to $49M in gross proceeds
EQUITY | Jun 24, 2026, 11:12 AM UTC
M
CALC: Continues Auxora Dosing
CalciMedica receives no FDA comments on its Phase 2 KOURAGE trial submission, allowing continued patient dosing with Auxora
EQUITY | Jun 24, 2026, 11:07 AM UTC
M
CALC: Raises $49M
CalciMedica announces private placement financing for up to approximately $49 million to advance pulmonary hypertension program
EQUITY | Jun 24, 2026, 11:03 AM UTC
M
CALC: Proceeds Auxora Dev
CalciMedica announces clinical development of Auxora may proceed following FDA review of KOURAGE trial interim safety data
EQUITY | Jun 24, 2026, 11:01 AM UTC
L
CalciMedica Issues Warrant
CalciMedica issues unregistered warrant to buy 1,000,000 shares at USD 1 each
EQUITY | Jun 24, 2026, 10:52 AM UTC